Tech Company Financing Transactions

Paradigm Diagnostics Funding Round

On 5/16/2019, Paradigm Diagnostics landed $15 million in Series B funding from BlueStone Venture Partners, Gore Range Capital and Mesa Verde Venture Partners.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

445 N. 5th St. 300
Phoenix, AZ 85004
USA

Phone

(844) 232-4719

Website

www.paradigmdx.com

Email Address

Not Recorded

Overview

Paradigm Diagnostics, Inc is a molecular information corporation established to bring comprehensive and clinically actionable cancer genomic profiling to physicians and patients.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

David Mallery

        

Chief Scientific Officer

Scott Morris

        

VP - Bus. Development

Bret Gustafson

        

VP - Operations

Troy Shelton

        

VP - R & D

Ariane Kemkes

        

VP - Sales

Michael Ostromecki

        

VP - Sales

Thomas Strilko

        

Browse more venture capital transactions:

Prev: 5/16/2019: Tealium venture capital transaction
Next: 5/16/2019: Phathom Pharmaceuticals venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary